드림씨아이에스

223250KOSDAQ자연과학 및 공학 연구개발업

63.9 / 100

Reference Date: 2026-06-10

Financial Score33.5 / 40

News Sentiment18.4 / 25

Momentum2.0 / 20

Disclosure10.0 / 15

AI Analysis: PER is significantly undervalued vs. peers and PBR is significantly undervalued vs. peers is also solid. Plunged 36.7% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

DreamCIS is a Contract Research Organization (CRO) that provides comprehensive services such as clinical trial design, data management, statistical analysis, and regulatory submissions for pharmaceutical companies. With over 25 years of experience and global expansion, the company is addressing growing demand for high-value drug development, including gene therapies and next-generation treatments.

Number of Employees

395people

Average Salary

55.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

13.23Industry Average 62.708.0Point

Half of industry avg (excellent)

PBR

1.13Industry Average 3.247.0Point

Half of industry avg (excellent)

ROE

9.25Industry Average -32.093.5Point

Well below industry avg

Debt Ratio

2.75Industry Average 7.316.5Point

Half of industry avg (excellent)

Trend 2023~20258.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲18.1% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲111.0% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 8.2% (improving, 3yr)

Detailed News Sentiment

4 totalPositive 3Neutral 1Negative 0Average Sentiment Score 73.8

Positive
부광약품, 드림씨아이에스·AWS와 전략적 MOU
드림씨아이에스와의 협력으로 부광약품의 AI 및 오가노이드 기술 기반 신약 개발이 가속화되어 긍정적인 시장 반응 예상.
Positive
AI 임상시험 전환 속도낸다…복지부 “만성질환·글로벌 협력 키운다.....
보건복지부의 AI 기반 임상시험 가속화 정책이 드림씨아이에스와 관련된 CRO(임상시험수행기관) 사업에 긍정적 영향을 미칠 것으로 예상됩니다.
Positive
"피투자사 기업가치만 2조 육박"…드림씨아이에스, '동반성장형 SI' ...
드림씨아이에스의 전략적 투자 모델이 성공적인 임상 결과와 기업 상장, 기술이전을 통해 긍정적인 성과를 거두고 있다.

Detailed Momentum

52-week position1.0Point

Near 52w low (18%, downtrend)

Current 3,955Won52-week high 7,69052-week low 3,120

1-month return0.0Point

1m -36.72% (strong drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

4 totalPositive 0Neutral 4Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-27
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-27
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-26
Neutral분기보고서 (2026.03)2026-05-14